GLP-1 drugs commonly used for weight loss and diabetes decreased the risk of cancer spreading in patients with several ...

A Cleveland Clinic study finds Ozempic-style GLP-1 drugs may significantly slow the spread of several obesity-related cancers ...

Add Yahoo as a preferred source to see more of our stories on Google. Brandee McKoon tried the traditional diets to lose weight but didn’t have much luck. The Kokomo woman was prediabetic when she ...

GLP-1 drugs may curb addiction and craving, making some patients less likely to drink alcohol. It could ease anxiety, ...

A study compared the association of semaglutide vs other antidiabetic medications and other GLP-1RAs, including liraglutide and dulaglutide, with opioid overdose risk in patients with comorbid type 2 ...

In a recent study published in The Lancet EBioMedicine, a team of scientists used Mendelian Randomization analyses to explore whether antidiabetic medications could potentially be used as ...

Although the use of glucagon-like peptide 1 (GLP-1) receptor agonists and other antidiabetic medications continues to increase among pregnant women with type 2 diabetes, current evidence suggests no ...

Compared with insulin alone, oral antidiabetic drugs alone or in addition to insulin were associated with reduced fracture risks among patients with type 2 diabetes. Oral antidiabetic drugs (OADs) are ...

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 new drug formulations including those ...

As multiple organs can be affected by diabetes, treatment nowadays extends beyond just controlling blood sugar levels.

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 new drug formulations, including Vitamin D3, anti-diabetic meds, cardiovascular drugs, and immunosuppressants, under ...